Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 4 Prostatic Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neurocognitive Disorders 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoglobulin G4-Related Disease 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Autoimmune Pancreatitis 1 Anus Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 2 enfortumab vedotin 1 Watchful Waiting 1 Specimen Handling 1 Observation 1 Magnetic Resonance Spectroscopy 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Observation × 30 days × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡